Gilde Healthcare appoints Jan Willem Bakker as Head of Investor Relations - Gilde Healthcare

Gilde Healthcare appoints Jan Willem Bakker as Head of Investor Relations

2. September 2024
Utrecht (the Netherlands)

Gilde Healthcare, the transatlantic specialist investment firm, is pleased to announce the addition of Jan Willem Bakker to its team as Partner & Head of Investor Relations.

Jan Willem will focus on Gilde Healthcare’s investor relations activities and contribute to the firm’s capital raising, marketing and communications efforts. With over 20 years of experience in client facing roles in financial services he brings vast experience to benefit existing and new LPs of the Gilde Healthcare platform. “We are pleased to welcome Jan Willem to our Investor Relations and Fundraising team,” said Pieter van der Meer, Managing Partner of Gilde Healthcare. “His extensive track record with institutional investors both as an LP and GP, strong industry relationships, and entrepreneurial mindset will help in strengthening our fundraising strategy and investor relationships. He will be instrumental in the foreseen expansion of our fund platform with impactful private equity strategies.”

Prior to joining Gilde Healthcare, Jan Willem was a partner at Prime Ventures having previously held senior roles at Arcano Partners and Adveq Management AG (now Schroders Capital), during his time at Adveq Jan Willem was a board member of the Dutch Private Equity association (NVP). He began his career in financial services at Kas Bank N.V. “I am very happy to join Gilde Healthcare’s ambitious team and contribute to building out its impactful platform. I look forward to collaborating with existing and prospective investors, investment and finance teams on delivering innovative and successful investment solutions to benefit a range of stakeholders.” said Jan Willem.

About Gilde Healthcare
Gilde Healthcare is a transatlantic specialist investment firm managing over €2.6 billion across two fund strategies: Venture&Growth and Private Equity. The Venture&Growth fund of Gilde Healthcare invests in fast growing companies active in digital health, medtech and therapeutics, based in Europe and North America. The Private Equity fund of Gilde Healthcare participates in profitable lower mid-market healthcare companies based in North-Western Europe. For more information, visit the company’s website at www.gildehealthcare.com.

Mehr neuigkeiten

Hermann Medizintechnik wird Teil von SPI, der spezialisierten MedTech CDMO-Plattform von Gilde Healthcare

Hermann Medizintechnik („Hermann") hat sich offiziell der Gruppe von Auftragsfertigern für komplexe chirurgische Instrumente und Implantate von Gilde Healthcare („SPI") angeschlossen. Damit erreicht SPI einen weiteren bedeutenden Meilenstein. Mit Hermann wächst SPI auf mehr als...
10. September 2026

BENTEC Endoscopy schließt sich der Auftragsfertigungsgruppe von Gilde Healthcare für chirurgische Instrumente und Implantate an

Die Gruppe von Auftragsfertigern für komplexe chirurgische Instrumente und Implantate von Gilde Healthcare („SPI") übernimmt BENTEC Endoscopy („BENTEC"). Die Transaktion ist ein weiterer bedeutender Meilenstein beim Aufbau einer führenden Gruppe für die Auftragsfertigung chirurgischer Instrumente....
27. August 2026

Gilde Healthcare portfolio company Synox Therapeutics announces positive topline results from the Phase 3 TANGENT study

TANGENT met its primary and secondary endpoints with a high level of statistical significance vs. placebo at 6 months, including ORR by RECIST V1.1 and Tumor Volume Score (TVS), and clinically meaningful improvements in PROMIS-PF...
13. April 2026